Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
1996 Phase I First clinical study Dorr et al
If thats your immediate association, weve got a comforting update for you
Which tissues respond best (muscle, endocrine, kidney, brain)
Doucette, C
515 Among patients receiving 150 mg or 300 mg of intravenous vedolizumab, the time to clinical remission was significantly better in patients receiving 300 mg of intravenous Vedolizumab than in patients receiving 150 mg of intravenous Vedolizumab
:max_bytes(150000):strip_icc()/GettyImages-2126120280-779987b12a5146d5b07f4e3ee57b3c3b.jpg)
US$ 24.56
US$ 21.42
US$ 20.02
US$ 25.74
US$ 20.22
